← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:126 | 126 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:126 | 126 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:126 | 126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-015 | 71449-015-06 | Atropine Sulfate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:126 | 126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-112 | 68985-112-95 | Azithromycin Anhydrous | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:126 | 126 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:126 | 126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3208 | 72627-3208-8 | Azelaic Acid; Ketoconazole; Minoxidil; Finasteride | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:126 | 126 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:126 | 126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-1 | Biotin | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:126 | 126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-1 | Atropine Sulfate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:126 | 126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6638 | 71300-6638-2 | Baclofen | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:126 | 126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1025 | 71266-1025-2 | Betamethasone Sodium Phosphate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:126 | 126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83556-0101 | 83556-0101-1 | Bevacizumab | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:126 | 126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-90 | Bevacizumab | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:126 | 126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-90 | Bevacizumab | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:126 | 126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0041 | 81483-0041-5 | Bevacizumab | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:127 | 127 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-57 | Ropivacaine Hydrochloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:127 | 127 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:127 | 127 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:127 | 127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-2 | Atropine Sulfate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:127 | 127 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azithromycin Dihydrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:127 | 127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-707 | 72833-707-02 | Avexitide | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:127 | 127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3111 | 72627-3111-1 | Azelaic Acid; Niacinamide; Metronidazole; Ivermectin | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:127 | 127 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:127 | 127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-087 | 73198-087-10 | Biotin | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:127 | 127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-508 | 65302-508-35 | Atropine Sulfate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:127 | 127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2406 | 72934-2406-2 | Benzocaine; Lidocaine; Tetracaine | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:127 | 127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-3 | Betamethasone Sodium Phosphate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:127 | 127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-458 | 69194-458-01 | Bevacizumab | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:127 | 127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-131 | 69194-131-01 | Bevacizumab | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:127 | 127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8006 | 71266-8006-1 | Bevacizumab | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:127 | 127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-131 | 69194-131-01 | Bevacizumab | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:128 | 128 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1042 | 73013-1042-2 | Hydromorphone HCl | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:128 | 128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:128 | 128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:128 | 128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-1 | Atropine Sulfate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:128 | 128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:128 | 128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-112 | 68985-112-91 | Azithromycin Anhydrous | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:128 | 128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3178 | 72627-3178-1 | Azelaic Acid; Niacinamide; Metronidazole; Ivermectin | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:128 | 128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:128 | 128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:128 | 128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:128 | 128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5404 | 72934-5404-4 | Benzocaine; Lidocaine; Tetracaine | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:128 | 128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:128 | 128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-963 | 69194-963-01 | Bevacizumab | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:128 | 128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0041 | 81483-0041-5 | Bevacizumab | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:128 | 128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0041 | 81483-0041-5 | Bevacizumab | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:128 | 128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2026-1 | source_no_ndc | 1 | 2026-10-13 | |||
compounder:129 | 129 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-95 | Heparin Sodium | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:129 | 129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:129 | 129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6000 | 71286-6000-1 | Atropine Sulfate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:129 | 129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6000 | 71286-6000-1 | Atropine Sulfate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:129 | 129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:129 | 129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azithromycin Dihydrate | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:129 | 129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3107 | 72627-3107-1 | Azelaic Acid; Niacinamide; Tretinoin | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:129 | 129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:129 | 129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:129 | 129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:129 | 129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5404 | 72934-5404-2 | Benzocaine; Lidocaine; Tetracaine | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:129 | 129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-43 | Bevacizumab | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:129 | 129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bimatoprost | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:129 | 129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bimatoprost | 2025-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-2:129 | 129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-131 | 69194-131-01 | Bevacizumab | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:129 | 129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83556-0101 | 83556-0101-1 | Bevacizumab | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:130 | 130 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-5355 | 71139-5355-1 | Sugammadex | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:130 | 130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:130 | 130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-1 | Atropine Sulfate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:130 | 130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:130 | 130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:130 | 130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:130 | 130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-112 | 68985-112-91 | Azithromycin Anhydrous | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:130 | 130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-43 | Bevacizumab | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:130 | 130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:130 | 130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:130 | 130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5429 | 26436-5429-2 | Benzocaine; Tetracaine; Lidocaine | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:130 | 130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-44 | Bevacizumab | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:130 | 130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9018 | 83826-9018-5 | Bimatoprost; Timolol Maleate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:130 | 130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9018 | 83826-9018-5 | Bimatoprost; Timolol Maleate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:130 | 130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83556-0101 | 83556-0101-1 | Bevacizumab | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:130 | 130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bimatoprost | 2026-1 | source_no_ndc | 1 | 2026-10-13 | |||
compounder:131 | 131 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6508 | 72934-6508-2 | Mavilo | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:131 | 131 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Apomorphine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:131 | 131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-2 | Atropine Sulfate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:131 | 131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1022 | 70657-1022-0 | Atropine Sulfate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:131 | 131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2601 | 72627-2601-4 | Benzyl Alcohol | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:131 | 131 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:131 | 131 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azithromycin Dihydrate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:131 | 131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-98 | Bevacizumab | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:131 | 131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-880 | 69852-880-10 | Brompheniramine Maleate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:131 | 131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-229 | 70092-229-43 | Atropine Sulfate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:131 | 131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-1 | Benzocaine; Tetracaine; Lidocaine | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:131 | 131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-22 | Bevacizumab | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:131 | 131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9032 | 83826-9032-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:131 | 131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9032 | 83826-9032-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:131 | 131 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2025-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2026-1:131 | 131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9018 | 83826-9018-5 | Bimatoprost; Timolol Maleate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:132 | 132 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1583 | 72934-1583-2 | Alomira | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:132 | 132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Arginine | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:132 | 132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:132 | 132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:132 | 132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2601 | 72627-2601-5 | Benzyl Alcohol | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:132 | 132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:132 | 132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azithromycin Dihydrate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:132 | 132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-589 | 72833-589-30 | Biotin | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:132 | 132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-970 | 69374-970-50 | Bupivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:132 | 132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-036 | 71506-036-01 | Atropine Sulfate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:132 | 132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-3 | Benzocaine; Tetracaine; Lidocaine | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:132 | 132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-98 | Bevacizumab | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:132 | 132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9003 | 83826-9003-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:132 | 132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9003 | 83826-9003-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:132 | 132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bimatoprost | 2025-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2026-1:132 | 132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9032 | 83826-9032-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:133 | 133 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1042 | 73013-1042-1 | Hydromorphone HCl | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:133 | 133 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Arginine | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:133 | 133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-015 | 71449-015-06 | Atropine Sulfate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:133 | 133 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:133 | 133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2600 | 72627-2600-4 | Benzyl Alcohol | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:133 | 133 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:133 | 133 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:133 | 133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-1 | Biotin | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:133 | 133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9160 | 71266-9160-2 | Bupivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:133 | 133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-137 | 73198-137-10 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:133 | 133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-4 | Benzocaine; Tetracaine; Lidocaine | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:133 | 133 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:133 | 133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5084 | 26436-5084-3 | Biotin | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:133 | 133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-2 | Biotin | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:133 | 133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9018 | 83826-9018-5 | Bimatoprost; Timolol Maleate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:133 | 133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9003 | 83826-9003-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:134 | 134 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9066 | 83826-9066-5 | Brimonidine Tartrate, Dorzolamide | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:134 | 134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2414 | 72627-2414-1 | Arginine Hydrochloride | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:134 | 134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-040 | 70004-040-07 | Atropine Sulfate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:134 | 134 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:134 | 134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2600 | 72627-2600-5 | Benzyl Alcohol | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:134 | 134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5057 | 26436-5057-3 | Benzocaine; Tetracaine; Lidocaine | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:134 | 134 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:134 | 134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-2 | Biotin | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:134 | 134 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:134 | 134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-112 | 68985-112-91 | Azithromycin Anhydrous | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:134 | 134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-6 | Benzocaine; Tetracaine; Lidocaine | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:134 | 134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-458 | 69194-458-01 | Bevacizumab | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:134 | 134 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Biotin | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:134 | 134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-1 | Biotin | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:134 | 134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9032 | 83826-9032-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:134 | 134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-087 | 73198-087-10 | Biotin | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:135 | 135 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0031 | 70168-0031-1 | Testo37.5mgCHOL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:135 | 135 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Arginine Hydrochloride; Propylparaben; Methylparaben | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:135 | 135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-040 | 70004-040-06 | Atropine Sulfate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:135 | 135 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:135 | 135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:135 | 135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5057 | 26436-5057-1 | Benzocaine; Tetracaine; Lidocaine | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:135 | 135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5057 | 26436-5057-1 | Benzocaine; Tetracaine; Lidocaine | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:135 | 135 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Biotin | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:135 | 135 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:135 | 135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6638 | 71300-6638-2 | Baclofen | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:135 | 135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-1 | Benzocaine; Tetracaine; Lidocaine | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:135 | 135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-091 | 71449-091-90 | Bevacizumab | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:135 | 135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1396 | 72934-1396-2 | Brimonidine Tartrate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:135 | 135 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Biotin | 2025-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-2:135 | 135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9003 | 83826-9003-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:135 | 135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-172 | 73198-172-10 | Biotin | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:136 | 136 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4601 | 72934-4601-8 | Hentis | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:136 | 136 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:136 | 136 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:136 | 136 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:136 | 136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1821 | 72907-1821-3 | Betamethasone Sodium Phosphate | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:136 | 136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5383 | 26436-5383-1 | Benzocaine; Tetracaine; Lidocaine | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:136 | 136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5433 | 26436-5433-1 | Benzocaine; Tetracaine; Lidocaine | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:136 | 136 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:136 | 136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0004 | 81483-0004-0 | Bupivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:136 | 136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6635 | 71300-6635-2 | Baclofen | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:136 | 136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1411 | 72934-1411-2 | Benzoyl Peroxide; Adapalene; Clindamycin Phosphate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:136 | 136 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:136 | 136 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:136 | 136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5084 | 26436-5084-3 | Biotin | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:136 | 136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5084 | 26436-5084-3 | Biotin | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:136 | 136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5084 | 26436-5084-3 | Biotin | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:137 | 137 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2040 | 70168-2040-1 | E2 15mg | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:137 | 137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-500 | 71591-500-50 | Ascorbic Acid | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:137 | 137 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:137 | 137 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:137 | 137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1015 | 71266-1015-1 | Betamethasone Sodium Phosphate | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:137 | 137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2601 | 72627-2601-5 | Benzyl Alcohol | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:137 | 137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5382 | 26436-5382-1 | Benzocaine; Tetracaine; Lidocaine | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:137 | 137 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:137 | 137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0003 | 81483-0003-0 | Bupivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:137 | 137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-1 | Benzocaine; Tetracaine; Lidocaine | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:137 | 137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1336 | 72934-1336-2 | Benzoyl Peroxide; Adapalene; Clindamycin Phosphate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:137 | 137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-963 | 69194-963-01 | Bevacizumab | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:137 | 137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-881 | 69852-881-10 | Brompheniramine Maleate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:137 | 137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1530 | 72934-1530-2 | Brimonidine Tartrate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:137 | 137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-2 | Biotin | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:137 | 137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2435 | 72627-2435-2 | Biotin | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:138 | 138 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-390 | 73693-390-01 | TESTOSTERONE 12.5 MG | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:138 | 138 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:138 | 138 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:138 | 138 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:138 | 138 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1015 | 71266-1015-2 | Betamethasone Sodium Phosphate | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:138 | 138 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2601 | 72627-2601-4 | Benzyl Alcohol | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:138 | 138 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2601 | 72627-2601-5 | Benzyl Alcohol | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:138 | 138 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:138 | 138 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-13 |